Quidel Corp. said Monday it has received federal approval to sell its AmpliVue test to detect C. difficile, a dangerous antibiotic-resistant microbe.
C. difficile infections can be deadly, especially for those who have been on antibiotics for a long time. Symptoms include nausea, fever, diarrhea & abdominal pain due to inflammation of the colon.
Our Dr Ohirra's OMX has been shown to counteract C. difficule.
Quidel said the AmpliVue test is superior to existing C. difficile tests because it is more accurate and faster. The C. difficile test is Quidel's first in the hand-held AmpliVue format, and is now available for sale in the U.S. as well as Europe, where it had been approved in March.
Quidel sells many diagnostic tests in various lines, including QuickVue, Thryetain, Sofia and Quidel Molecular. In November, Quidel received European approval to sell its Sofia Legionella FIA to detect Legionnaires' disease.
Union Tribune San Diego
31 January 2013